Prepared Remarks:

Operator

Ladies and gentlemen, good morning, and welcome to the CVS Health second quarter 2022 earnings conference call. [Operator instructions] As a reminder, today's conference is being recorded. I would now like to turn the call over to Larry McGrath, senior vice president of business development and investor relations for CVS Health. Please go ahead.

Larry McGrath -- Senior Vice President, Business Development and Investor Relations

Good morning, and welcome to the CVS Health second quarter 2022 earnings call and webcast. I'm Larry McGrath, senior vice president of business development and investor relations. I'm joined this morning by Karen Lynch, president and chief executive officer; and Shawn Guertin, executive vice president and chief financial officer. Following our prepared remarks, we'll host a question-and-answer session that will include Dr.

Alan Lawson, president of pharmacy services; Dan Finke, president healthcare benefits; Michelle Peluso, chief customer officer and co-president, retail; and Prem Shah, chief pharmacy officer and co-president, retail; as well as Tom Carey, senior vice president, capital markets. Our press release and slide presentation has been posted to our website, along with our Form 10-Q that was filed this morning with the SEC. Today's call is also being broadcast on our website, where it will be archived for one year. During this call, we'll make certain forward-looking statements reflecting current views related to our future financial performance, future events, including potential impacts related to COVID-19 and industry and market conditions, as well as the expected consumer benefits of our products and services and our financial projections.

Our forward-looking statements are subject to significant risks and uncertainties that could cause actual results to differ materially from currently projected results. We strongly encourage you to review the reports we file with the SEC regarding these risks and uncertainties, including our most recent annual report on Form 10-K, our recent current reports on Form 8-K, this morning's earnings press release, and our Form 10-Q. During this call, we'll use non-GAAP measures when talking about the company's performance and financial conditions, and you'll find a reconciliation of these non-GAAP measures in this morning's press release and on the reconciliation documents posted to the Investor Relations portion of our website. With that, I'd like to turn the call over to Karen.